Abstract:Alveolar echinococcosis (AE) is a chronic and fatal infectious parasitic disease, which has not been well-researched. Current recommended therapies for AE by the World Health Organization include complete removal of the infected tissue followed by two years of albendazole (ABZ), administered orally, which is the only effective first-line anti-AE drug. Unfortunately, in most cases, complete resection of AE lesions is impossible, requiring ABZ administration for even longer periods. Only one-third of patients experienced complete remission or cure with such treatments, primarily due to ABZ's low solubility and low bioavailability. To improve ABZ bioavailability, albendazole bile acid derivative (ABZ-BA) has been designed and synthesized. Its structure was identified by mass spectrometry and nuclear magnetic resonance. Its physicochemical properties were evaluated by wide-angle X-ray diffraction, differential scanning calorimetry, scanning electron microscopy, and polarizing microscopy; it was compared with ABZ to assess its solubilization mechanism at the molecular level. To avoid the effects of bile acid on the efficacy of albendazole, the inhibitory effect of ABZ-BA on protoscolex (PSCs)s was observed in vitro . The inhibitory effect of ABZ-BA on PSCs was evaluated by survival rate, ultrastructural changes, and the expression of key cytokines during PSC apoptosis. The results showed that ABZ-BA with 4-amino-1-butanol as a linker was successfully prepared. Physicochemical characterization demonstrated that the molecular arrangement of ABZ-BA presents a short-range disordered amorphous state, which changes the drug morphology compared with crystalline ABZ. The equilibrium solubility of ABZ-BA was 4-fold higher than ABZ in vitro . ABZ-BA relative bioavailability (F rel ) in Sprague-Dawley (SD) rats was 26-fold higher than ABZ in vivo . The inhibitory effect of ABZ-BA on PSCs was identical to that of ABZ, indicating that adding bile acid did not affect the efficacy of anti-echinococcosis. In the pharmacodynamics study, it was found that the ABZ-BA group had 2.7-fold greater than that of Albenda after 1 month of oral administration. The relative bioavailability of ABZ-BA is significantly better than ABZ due to the transformation of the physical state from a crystalline state to an amorphous state. Furthermore, sodium-dependent bile acid transporter (ASBT) expressed in the apical small intestine has a synergistic effect through the effective transport of bile acids. Therefore, we concluded that the NC formulation could potentially be developed to improve anti-AE drug therapy. Alveolar echinococcosis (AE) is a neglected zoonotic parasitic disease caused by Echinococcus multilocularis ( E . multilocularis ). This parasitic infection can cause severe damage to the liver, lungs, and other human or animal organs, which can be fatal if left untreated. The 10-year mortality rate for patients with untreated or improperly treated AE is greater than 90%. Therefore, AE is also called as "worm cancer". Benzimidazoles, including the first-line drug ABZ, are considered the only effective drug against AE. However, ABZ has a low and erratic oral bioavailability due to its low solubility,which has partially led to unsatisfactory clinical efficacy of this oral drug. In this study, albendazole bile acid derivatives were prepared to improve the anti- Echinococcus multilocularis effect. The synergistic effect of steric hindrance and transmembrane transport increased the equilibrium solubility of ABZ-BA in vitro by nearly 4-fold and the bioavailability in vivo by about 90-fold. The in vivo study demonstrated that the pharmacokinetic behavior of the ABZ-BA was superior to that of Albenda. In the pharmacodynamics study, it was also found that the ABZ-BA group had a significant therapeutic effect after 1 month of oral administration. This albendazole bile acid derivative provides an effective and translatable novel approach to oral drug therapy for chronic, fatal, and neglected parasitic infectious alveolar echinococcosis.

Effect of Albendazole Upon Activity of Energy Metabolic Enzymes of Cysticercus Cellulosae in Swine Bodies

An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes

Efficacy and mechanism of energy metabolism dual-regulated nanoparticles (atovaquone-albendazole nanoparticles) against cystic echinococcosis

Impacts of changes in intestinal flora on the metabolism of Sprague-Dawley rats

In Vitro and in Vivo Efficacies of Carbazole Aminoalcohols in the Treatment of Alveolar Echinococcosis.

In Vitro Effects of Amino Alcohols on Echinococcus Granulosus

Metabolic mechanism and pharmacological study of albendazole in secondary hepatic alveolar echinococcosis (HAE) model rats

Suppressive effect of pseudolaric acid B on Echinococcus multilocularis involving regulation of TGF-β1 signaling in vitro and in vivo

Digest the Sugar, Kill the Parasite: A New Experimental Concept in Treating Alveolar Echinococcosis

Improvement of Antialveolar echinococcosis efficacy of novel Albendazole-Bile acids Derivatives with Enhanced Oral Bioavailability

Anticoccidial Effect of Halofuginone Hydrobromide Against Eimeria Tenella with Associated Histology

Effect of Chiral Differences of Metolachlor and Its (S)-Isomer on Their Toxicity to Earthworms

In Vivo and in Vitro Efficacies of Mebendazole, Mefloquine and Nitazoxanide Against Cyst Echinococcosis

Effectiveness of benzimidazole treatments against Haemonchus contortus in sheep and goats - do they produce similar responses?

Application of a cDNA microarray for profiling the gene expression of Echinococcus granulosus protoscoleces treated with albendazole and artemisinin

Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis

Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses

In vitro efficacies of solubility-improved mebendazole derivatives against Echinococcus multilocularis.

In vitro inhibitive effect of the anticancer drug sorafenib on Echinococcus multilocularis larvae

The protective effects of benzaldehyde combined with albendazole against brain injury induced by Angiostrongylus cantonensis infection in mice.

Regulatory effect of Balanites aegyptiaca ethanol extract on oxidant/antioxidant status, inflammatory cytokines, and cell apoptosis gene expression in goat abomasum experimentally infected with Haemonchus Contortus